EUVIMEDEUVIMED entdecken
Crossref

Overcoming solubility challenges of eplerenone via nanomicelles-driven strategy

Asmaa M. Rashid, Hiba M. Suza, Hawraa K. Khafeef, Noor Najim Alwiswasi, Muna Yehia, Worood Hameed Al-zheery

ACTA Pharmaceutica Sciencia · 2026 · 64 (3) · 425

DOI: 10.23893/1307-2080.aps64022 ↗

Kurz gefasst

Fachartikel in der Zeitschrift ACTA Pharmaceutica Sciencia, 2026. Verfasst von Asmaa M. Rashid und 5 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Zitieren

APA

Rashid, A. M., Suza, H. M., Khafeef, H. K., Alwiswasi, N. N., Yehia, M., & Al-zheery, W. H. (2026). Overcoming solubility challenges of eplerenone via nanomicelles-driven strategy. ACTA Pharmaceutica Sciencia, 64(3), 425. https://doi.org/10.23893/1307-2080.aps64022

Vancouver

Rashid AM, Suza HM, Khafeef HK, Alwiswasi NN, Yehia M, Al-zheery WH. Overcoming solubility challenges of eplerenone via nanomicelles-driven strategy. ACTA Pharmaceutica Sciencia. 2026;64(3):425. doi:10.23893/1307-2080.aps64022

BibTeX
@article{Rashid2026,
  author = {Rashid, Asmaa M. and Suza, Hiba M. and Khafeef, Hawraa K. and Alwiswasi, Noor Najim and Yehia, Muna and Al-zheery, Worood Hameed},
  title = {Overcoming solubility challenges of eplerenone via nanomicelles-driven strategy},
  journal = {ACTA Pharmaceutica Sciencia},
  year = {2026},
  volume = {64},
  number = {3},
  pages = {425},
  doi = {10.23893/1307-2080.aps64022}
}
Kostenlos starten →